{
  "id": "GALAD_Model_for_Hepatocellular_Carcinoma_HCC_guideline.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2020-08-13",
      "name": "Maryam Razavi",
      "organisation": "CambioCDS",
      "email": "maryam.razavi@cambio.se"
    },
    "lifecycle_state": "Author draft",
    "details": {
      "en": {
        "id": "en",
        "purpose": "To estimate the risk that a CLD patient has HCC using only tumor markers and demographics (i.e., no imaging).",
        "keywords": [
          "Hepatocellular Carcinoma",
          "AFP-L3",
          "Alpha fetoprotein (AFP)",
          "Des-carboxy-prothrombin (DCP)"
        ],
        "use": "Use in patients with chronic liver disease (CLD).\nFormula\nGALAD Score = -10.08 + 0.09 x A + 1.67 x G + 2.34 log10(AF) + 0.04 x L + 1.33 x log10(D)\nWhere variables are as follows:\nGender: 0 if female, 1 if male\nAge: Age, years\nAFP-L3: Alpha fetoprotein L3, %\nAFP: Alpha fetoprotein, ng/mL\nDCP: Des-carboxy-prothrombin, ng/mL\n\n\n\n",
        "copyright": "@CambioCDS"
      }
    },
    "other_details": {
      "references": "1. Johnson PJ, Pirrie SJ, Cox TF, et al. The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers. Cancer Epidemiol Biomarkers Prev. 2014;23(1):144-53.\n2. Best J, Bilgi H, Heider D, et al. The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma. Z Gastroenterol. 2016;54(12):1296-1305.\n3. Kumada T, Toyoda H, Kiriyama S, et al. Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus. J Gastroenterol. 2011;46(4):536-44.\n"
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-OBSERVATION.galad_model_for_hepatocellular_carcinoma_hcc.v0",
        "template_id": "openEHR-EHR-OBSERVATION.galad_model_for_hepatocellular_carcinoma_hcc.v0",
        "type": "INPUT",
        "elements": {
          "gt0003": {
            "id": "gt0003",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0004]"
          },
          "gt0004": {
            "id": "gt0004",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0007]"
          },
          "gt0005": {
            "id": "gt0005",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0008]"
          },
          "gt0006": {
            "id": "gt0006",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0009]"
          },
          "gt0007": {
            "id": "gt0007",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0010]"
          }
        }
      },
      "gt0008": {
        "id": "gt0008",
        "model_id": "openEHR-EHR-OBSERVATION.galad_model_for_hepatocellular_carcinoma_hcc.v0",
        "template_id": "openEHR-EHR-OBSERVATION.galad_model_for_hepatocellular_carcinoma_hcc.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0009": {
            "id": "gt0009",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0011]"
          },
          "gt0010": {
            "id": "gt0010",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0012]"
          }
        }
      }
    },
    "rules": {
      "gt0011": {
        "id": "gt0011",
        "priority": 2,
        "when": [
          "$gt0003|Gender|!=null",
          "$gt0004|Age|!=null",
          "$gt0005|AFP-L3|!=null",
          "$gt0006|AFP|!=null",
          "$gt0007|DCP|!=null"
        ],
        "then": [
          "$gt0009|GALAD Score|.magnitude=(0.09*$gt0004.magnitude+1.67*$gt0003.value+2.34*log10($gt0006.magnitude)+0.04*$gt0005.magnitude+1.33*log10($gt0007.magnitude))-10.08",
          "$gt0009|GALAD Score|.precision=2",
          "$gt0009|GALAD Score|.unit='1'"
        ]
      },
      "gt0012": {
        "id": "gt0012",
        "priority": 1,
        "when": [
          "$gt0009|GALAD Score|!=null"
        ],
        "then": [
          "$gt0010|Probability of concurrent HCC in this CLD patient|.magnitude=(exp($gt0009.magnitude)/(1+exp($gt0009.magnitude)))*100",
          "$gt0010|Probability of concurrent HCC in this CLD patient|.unit='%'",
          "$gt0010|Probability of concurrent HCC in this CLD patient|.precision=2"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "GALAD Model for Hepatocellular Carcinoma (HCC)",
            "description": "GALAD Model for Hepatocellular Carcinoma (HCC) diagnoses HCC based on serum biomarkers in patients with chronic liver disease (CLD)."
          },
          "gt0003": {
            "id": "gt0003",
            "text": "Gender",
            "description": "*"
          },
          "gt0004": {
            "id": "gt0004",
            "text": "Age",
            "description": "*"
          },
          "gt0005": {
            "id": "gt0005",
            "text": "AFP-L3",
            "description": "*"
          },
          "gt0006": {
            "id": "gt0006",
            "text": "AFP",
            "description": "*"
          },
          "gt0007": {
            "id": "gt0007",
            "text": "DCP",
            "description": "*"
          },
          "gt0009": {
            "id": "gt0009",
            "text": "GALAD Score",
            "description": "*"
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Probability of concurrent HCC in this CLD patient",
            "description": "*"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Set GALAD score"
          },
          "gt0012": {
            "id": "gt0012",
            "text": "Set Probability of HCC "
          }
        }
      }
    }
  }
}